Primary Care Physicians, Endocrinologists, Certified Diabetes Educators
Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), Diabetic Eye Disease
1. | Refer patients to an eye care specialist annually for early detection of DR and DME | 2. | Counsel patients regarding the importance of annual eye examinations in early detection of DR and DME for prevention of vision loss |
3. | Select glycemic control agents least likely to contribute to DME | 4. | Incorporate the results of eye examinations and DME treatment into patient counseling |
5. | Describe special considerations for care of underserved patient populations | 6. | Integrate effective communication and coordination of patient care with eye care specialists |
1. | Refer patients to an eye care specialist annually for early detection of DR and DME |
2. | Counsel patients regarding the importance of annual eye examinations in early detection of DR and DME for prevention of vision loss |
3. | Select glycemic control agents least likely to contribute to DME |
4. | Incorporate the results of eye examinations and DME treatment into patient counseling |
5. | Describe special considerations for care of underserved patient populations |
6. | Integrate effective communication and coordination of patient care with eye care specialists |
Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
Name/Role | Commercial Entity With Whom There Is a Relevant Financial Relationship (or None) | Nature of Relevant Financial Relationship With Commercial Entity (Speaker, Consultant, etc) | |
What was received? | For what role? | ||
David M. Brown, MD, FACS (PC) | Alcon; Allergan; Bayer; Genentech; Novartis; Regeneron; ThromboGenics | Fee (All listed) | Consultant |
Aerpio; Alcon; Allergan; Ampio; Genentech; Novartis; Pfizer; Regeneron; ThromboGenics | Contracted Research | ||
Michael J. Elman, MD (PC) | Genentech/Roche; OHR Pharmaceutical | Fee (All listed) | Consultant |
Scienomics | Fee | Speakers Bureau | |
Jaeb Center, OHR Pharmaceutical | Fee | Contracted Research | |
OHR Pharmaceutical | Fee | Stock Shareholder | |
Anne Peters, MD (PC) | Bristol-Myers Squibb; AstraZeneca; Novo Nordisk | Fee (All listed) | Speakers Bureau |
Medscape | Editorial Fees | | |
Abbott Diabetes Care; Becton, Dickinson; Bristol-Myers Squibb; AstraZeneca; Janssen; Lilly; Medtronic | Fee (All listed) | Consultant | |
Medtronic MiniMed | Fee | Contracted Research | |
Diane McArdle, PhD (C) | None | | |
John Sorenson, MD (PR) | None | | |
Cynthia Tornallyay, RD, MBA, CCMEP (C) | None | | |
Betty Villafuerte, MD (CD) (PR) | None | | |